Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Analysis of Investments

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities

Edwards Lifesciences Corp., adjustment to net income

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net income (as reported)
Add: Unrealized gain (loss) on available-for-sale investments
Less: Reclassification of net realized investment loss to earnings
Net income (adjusted)

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


The financial data presented indicates notable patterns in both reported and adjusted net income over the period from December 31, 2017, to December 31, 2021.

Reported Net Income
The reported net income shows a consistent upward trend over the observed years. Starting at $583,600 thousand in 2017, it increased to $722,200 thousand in 2018, representing a significant rise. The growth continued in 2019, reaching $1,046,900 thousand, which marks the most substantial year-over-year increase during the period. Following a slight decline in 2020 to $823,400 thousand, the income rebounded sharply in 2021 to $1,503,100 thousand, achieving the highest value in the five-year span.
Adjusted Net Income
Adjusted net income follows a similar trajectory as the reported net income, reflecting parallel growth trends. It rose from $578,900 thousand in 2017 to $721,800 thousand in 2018, closely aligning with the reported figures. In 2019, the adjusted net income peaked at $1,053,600 thousand, slightly surpassing the reported net income for the same year. The 2020 value dipped to $830,300 thousand, mirroring the pattern seen in reported net income, before markedly increasing to $1,487,600 thousand in 2021.
Comparative Analysis
The proximity of the adjusted net income values to the reported net income throughout the period suggests limited adjustments affecting net income figures. The strongest growth phases occurred between 2018 and 2019 as well as 2020 and 2021, indicating periods of improved profitability. The 2020 decline in both measures may reflect external or operational challenges specific to that year, followed by substantial recovery.

Adjusted Profitability Ratios: Mark to Market Available-for-sale Securities (Summary)

Edwards Lifesciences Corp., adjusted profitability ratios

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net Profit Margin
Reported net profit margin
Adjusted net profit margin
Return on Equity (ROE)
Reported ROE
Adjusted ROE
Return on Assets (ROA)
Reported ROA
Adjusted ROA

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


Net Profit Margin
The reported net profit margin demonstrates a generally positive trend with fluctuations. Starting at 16.99% in 2017, it increased steadily to 24.08% by 2019, followed by a decline to 18.77% in 2020, and then showed a significant rebound to 28.73% in 2021. The adjusted net profit margin follows a similar pattern, closely mirroring the reported figures, indicating consistency in adjustments and underlying profitability trends.
Return on Equity (ROE)
The reported ROE exhibits a pattern of growth and decline over the analysis period. It rose from 19.74% in 2017 to a peak of 25.24% in 2019, dropped sharply to 18.00% in 2020, and then recovered to 25.76% in 2021. The adjusted ROE displays a comparable trajectory, with values slightly varying but showing the same pattern of increase, decline, and subsequent recovery. This suggests a temporary decline in profitability that was recovered by the end of the period.
Return on Assets (ROA)
ROA trends indicate overall growth with a dip in the middle years. The reported ROA increased from 10.25% in 2017 to 16.14% in 2019, decreased to 11.38% in 2020, and then rose again to 17.68% in 2021. The adjusted ROA mirrors this progression with minimal differences, reaffirming the robustness of operational efficiency metrics despite the downturn in 2020.
General Observations
Across all key financial indicators—net profit margin, ROE, and ROA—there is a noticeable pattern of growth from 2017 to 2019, a decline in 2020, followed by a strong recovery in 2021. The consistency between reported and adjusted figures suggests that non-recurring items or accounting adjustments have had limited impact on the overall financial performance trends. The dip in 2020 may be attributable to external factors affecting the company’s profitability and efficiency, although the prompt recovery in 2021 reflects resilience and effective management.

Edwards Lifesciences Corp., Profitability Ratios: Reported vs. Adjusted


Adjusted Net Profit Margin

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income
Net sales
Profitability Ratio
Net profit margin1
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in thousands)
Adjusted net income
Net sales
Profitability Ratio
Adjusted net profit margin2

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

2021 Calculations

1 Net profit margin = 100 × Net income ÷ Net sales
= 100 × ÷ =

2 Adjusted net profit margin = 100 × Adjusted net income ÷ Net sales
= 100 × ÷ =


The financial data displays a positive overall trend in both reported and adjusted net income between 2017 and 2021. Reported net income increased substantially from $583.6 million in 2017 to $1.5031 billion in 2021. Similarly, adjusted net income grew from $578.9 million to $1.4876 billion over the same period, indicating a consistent and progressive improvement in profitability.

The net profit margins for both reported and adjusted figures follow a similar upward trajectory. The reported net profit margin rose from 16.99% in 2017 to 28.73% in 2021, while the adjusted net profit margin increased from 16.85% to 28.43%. Notably, both margins peaked in 2021, suggesting enhanced operational efficiency or improved revenue quality during that year.

Examining the year-over-year changes, net income demonstrated steady growth with the exception of 2020, where reported net income declined to $823.4 million from $1.0469 billion in 2019. This dip is mirrored in the adjusted net income, which decreased slightly to $830.3 million in 2020 from $1.0536 billion in 2019. The corresponding net profit margins also reflect this downturn, dropping from their 2019 highs to 18.77% and 18.93% for reported and adjusted figures, respectively, in 2020.

This temporary decline in 2020 may suggest external challenges impacting earnings, followed by a strong recovery in 2021. The significant rebound in 2021 net income and net profit margins indicates effective management responses or favorable market conditions that restored and improved profitability beyond previous levels.

The close alignment between reported and adjusted figures throughout the period highlights consistency in financial reporting and relatively stable adjustments, enhancing confidence in the reliability of the presented profitability trends.


Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income
Stockholders’ equity
Profitability Ratio
ROE1
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in thousands)
Adjusted net income
Stockholders’ equity
Profitability Ratio
Adjusted ROE2

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

2021 Calculations

1 ROE = 100 × Net income ÷ Stockholders’ equity
= 100 × ÷ =

2 Adjusted ROE = 100 × Adjusted net income ÷ Stockholders’ equity
= 100 × ÷ =


The financial data over the five-year span from 2017 to 2021 reveals notable trends in reported and adjusted net income, as well as corresponding return on equity (ROE) figures.

Net Income Trends
Both reported and adjusted net income figures demonstrate an overall upward trajectory across the period. Reported net income increased from approximately 584 million US dollars in 2017 to over 1.5 billion US dollars in 2021. Adjusted net income followed a very similar pattern, increasing from about 579 million US dollars in 2017 to nearly 1.49 billion US dollars by 2021. The small differences between reported and adjusted values indicate consistency between the two measures, with adjustments having minimal impact on net income amounts.
Return on Equity (ROE) Trends
Reported ROE exhibited growth from 19.74% in 2017 to a peak of 25.24% in 2019, followed by a decrease to 18% in 2020, and then a recovery to 25.76% in 2021. Adjusted ROE mirrored this pattern closely, increasing from 19.58% in 2017 to 25.4% in 2019, dropping slightly to 18.15% in 2020, and rising again to 25.49% in 2021. These fluctuations suggest a temporary decline in profitability or efficiency in 2020, with a strong rebound the following year.
Interpretation of Trends
The consistent increase in net income indicates a robust earnings growth trajectory. The dip in ROE in 2020 potentially reflects external challenges or increased equity base impacting returns within that year. The rapid recovery in 2021 highlights resilience and improved return generation on shareholder equity. The close alignment between reported and adjusted figures across all metrics suggests financial reporting stability and consistent operational performance.

Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income
Total assets
Profitability Ratio
ROA1
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in thousands)
Adjusted net income
Total assets
Profitability Ratio
Adjusted ROA2

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

2021 Calculations

1 ROA = 100 × Net income ÷ Total assets
= 100 × ÷ =

2 Adjusted ROA = 100 × Adjusted net income ÷ Total assets
= 100 × ÷ =


The financial data indicates that both reported and adjusted net income for the company exhibited a generally upward trend over the five-year period from 2017 to 2021. Specifically, reported net income increased from $583.6 million in 2017 to $1.5031 billion in 2021, reflecting significant growth especially between 2020 and 2021. Adjusted net income followed a similar pattern, increasing from $578.9 million in 2017 to $1.4876 billion in 2021. The values for reported and adjusted net income are closely aligned in each year, suggesting limited differences between the reported figures and those adjusted for non-recurring items or other factors.

Regarding profitability ratios, both reported and adjusted Return on Assets (ROA) reveal analogous trends. The reported ROA started at 10.25% in 2017, rising steadily to peak at 16.14% in 2019 before declining to 11.38% in 2020, and then surging to a five-year high of 17.68% in 2021. Adjusted ROA values show a similar pattern, beginning at 10.16% in 2017, increasing to 16.24% in 2019, dipping slightly to 11.47% in 2020, and then climbing to 17.5% in 2021. The close correspondence between reported and adjusted ROA across all years indicates that asset performance measures are consistent regardless of adjustments.

In summary, the data reveals solid and improving profitability and net income over the period, with a notable dip in asset returns during 2020 which may be attributed to external challenges that year. The recovery and marked improvement in both net income and ROA in 2021 underscore enhanced operational efficiency or favorable market conditions driving stronger financial performance. The minimal differences between reported and adjusted figures imply stable underlying financial operations without significant one-time distortions.